3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
5
Heart Diseases
3
Carcinoma, Non-Small-Cell Lung
3
Vascular Diseases
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Small Cell Lung Carcinoma
1
Metabolic Diseases
1
Liver Neoplasms
1
Hematologic Neoplasms
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Cancer Therapy-related Cardiovascular Toxicity
1
Interventions
Surveys and Questionnaires
7
Interviews as Topic
7
Blood Specimen Collection
5
Specimen Handling
4
Exercise Test
4
fludarabine
3
Voriconazole
3
Mental Status and Dementia Tests
3
Bortezomib
3
Standard of Care
2
Observation
2
Itraconazole
2
Flow Cytometry
2
Electronic Health Records
2
Data Collection
2
Antiviral Agents
2
posaconazole
1
liposomal amphotericin B
1
isavuconazole
1
glucarpidase
1
fludarabine phosphate
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
Whole-Body Irradiation
1
Watchful Waiting
1
Vincristine
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Tomography, Optical Coherence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hematologic Neoplasms
×
Antineoplastic Agents
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled